Search

everythinglearnresearchcommunity

for

Search:↓

Trichodynia is a painful scalp condition linked to hair loss and mental health issues, with limited treatment options.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

For sensitive scalp, treatment is personalized and may include specific medications and hydration, while avoiding stress and irritating products.

Sensitive scalp causes discomfort and hair loss, treated with personalized care.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.

Long hair can cause hair loss due to constant pulling.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Accurate early diagnosis of Lichen Planopilaris is crucial to prevent permanent hair loss.

Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Psychological factors like depression may be more important than zinc, folate, and vitamin B12 levels in causing scalp pain in people with hair loss.

Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.

The study found no link between anxiety, vitamin B12, folate, TSH, ferritin, zinc levels, and trichodynia in telogen alopecia patients.

The conclusion is that "trichoknesis" should be recognized as a separate condition from trichodynia, characterized by itching instead of pain.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.

Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.

People with hair loss conditions like Telogen Effluvium and Alopecia Areata often feel scalp pain and are more likely to have anxiety, but not necessarily depression.

Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.

Hair loss can cause scalp discomfort.